drugset / Trial / NCT00884325

Management of Pruritus With Xyzal in Atopic Dermatitis

NCT00884325

Phase 4 Completed 40 enrolled Derm Research, PLLC UCB Pharma · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

It is historically well known that the management of pruritus in atopic dermatitis is very difficult. Most of the patients are not controlled with traditional antihistamines such as Clarinex, Claritin, and Allegra. It will be a welcome addition to our treatment armamentarium if a drug such as Xyzal can control pruritus associated with atopic dermatitis.

Timeline

Start
2009-02
Primary completion
2010-01
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Levocetirizine Unknown 5 mg Oral

Indications